[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365863-105":59,"doc-detail-365863-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","atpase-copper-transporting-beta-attenuates-malignant-features-with-high-expression-as-an-indicator-of-favorable-prognosis-in-breast-cancer","ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer","","ATPase copper transporting beta (ATP7B) is a copper-transporting ATPase that ejects copper from cells, and high ATP7B expression has been linked to cisplatin resistance, while its relevance in breast cancer remains unclear. This study assessed ATP7B mRNA and protein expression in breast cancer and non-cancerous mammary cell lines, and used PCR array profiling to relate ATP7B to 84 cancer-related genes. ATP7B knockdown via small interfering RNA was performed to evaluate proliferation, invasiveness, and migration, and correlations between ATP7B expression and clinicopathological features were analyzed in 156 patients. Results showed ATP7B was highly expressed in ER-positive and HER2-positive cell lines, with ATP7B correlating with cadherin 1, estrogen receptor 1, and MET. Knockdown increased malignant behaviors in tested cell models, and high ATP7B expression at both mRNA and protein levels predicted favorable outcomes as an independent prognostic factor.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/atpase-copper-transporting-beta-attenuates-malignant-features-with-high-expression-as-an-indicator-of-favorable-prognosis-in-breast-cancer/365863/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/atpase-copper-transporting-beta-attenuates-malignant-features-with-high-expression-as-an-indicator-of-favorable-prognosis-in-breast-cancer/365863.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Does ATP7B expression have prognostic value for breast cancer patients?","Question",{"text":112,"@type":113},"High ATP7B expression at both mRNA and protein levels was associated with favorable prognoses, and ATP7B expression was identified as an independent prognostic factor in multivariate analysis.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},365863,1790490115,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Breast Cancer (2025) 32:803–815  \n[https://doi.org/10.1007/s12282-025-01705-7](https://doi.org/10.1007/s12282-025-01705-7)  \nATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer  \nIkumi Soeda1 · Masahiro Shibata1,2 · Takahiro Inaishi1,3 · Takahiro Ichikawa1 · Kayoko Sugino1 · Emi Kanaya4 · Mitsuro Kanda5 · Masamichi Hayashi5 · Norikazu Masuda1  \nReceived: 24 February 2025 / Accepted: 14 April 2025 / Published online: 2 May 2025 © The Author(s) 2025  \nAbstract  \nBackground ATPase copper transporting beta (ATP7B) functions as a copper-transporting ATPase that ejects copper from cells. Although high expression of ATP7B has been reported to increase cisplatin resistance, its role in breast cancer (BC) remains unclear. This study aimed to elucidate the function of ATP7B in BC cells and its significance in patients with BC. Methods The mRNA and protein expression levels of ATP7B were evaluated in BC and non-cancerous mammary cell lines. Polymerase chain reaction (PCR) array analysis was conducted to determine the correlation between ATP7B and 84 cancer-related genes. ATP7B knockdown was performed using small interfering RNA, and cell proliferation, invasiveness, and migration were analyzed. The associations between the mRNA and protein expression of ATP7B and clinicopathological factors were also investigated in 156 patients with BC.  \nResults ATP7B was found to be highly expressed in estrogen receptor-positive and human epidermal growth factor receptor 2-positive BC cell lines. PCR array analysis revealed a significant correlation between the expression level of ATP7B and those of cadherin 1, estrogen receptor 1, and MET proto-oncogene. ATP7B knockdown significantly increased the proliferation, invasiveness, and migration of MDA-MB-361 and MDA-MB-415 cells. Patients with high ATP7B expression atthe mRNA and protein levels experienced favorable prognoses. In addition, ATP7B expression level was identified as an independent prognostic factor in multivariate analysis.  \nConclusions ATP7B is involved in promoting anti-cancer activities of tumor suppressors in BC cells across different subtypes and is considered a prognostic marker for BC.  \nKeywords ATPase copper transporting beta · Breast cancer · Estrogen receptor · Prognostic marker  \n* Masahiro Shibata [shibatamasahiro1124@yahoo.co.jp](shibatamasahiro1124@yahoo.co.jp)  \n1 Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan  \n2 Department of Surgery, Nagoya Ekisaikai Hospital, 4-66, Shonen-cho, Nakagawa-ku, Nagoya 454-8502, Japan  \n3 Department of Surgery, Komaki City Hospital, 1-20, Joubushi, Komaki, Aichi 485-8520, Japan  \n4 Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan  \n5 Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan  \nIntroduction  \nBreast cancer (BC) is the most common cancer in women worldwide [1] . BC is classified via immunohistochemical analysis using conventional targets, including the estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2), and is treated according to the classification. Although several therapeutic agents are available and are still being developed, the 5-year survival rate of patients with distant metastases is as low as 27%, indicating that curing BC remains difficult [1] . Therefore, new biomarkers and therapeutic target molecules are needed to improve the prognosis of patients with BC.  \nATPases are a general term for enzymes that hydrolyze the phosphate bonds of adenosine triphosphate and convert the energy obtained by hydrolysis to other tasks. The  \na  \n0.0025  \nRelative ATP 7B mRNA expression level  \n0.0020 0.0015 0.0010  \n0.0005  \n0 ","cbCaioyGpzLwKsov","https://ap.wps.com/l/cbCaioyGpzLwKsov","pdf",1557138,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Breast cancer classification and prognosis\n## Need for new biomarkers\n## ATPases and ATP7B overview\n# Experimental framework and key findings","[{\"question\":\"Does ATP7B expression have prognostic value for breast cancer patients?\",\"answer\":\"High ATP7B expression at both mRNA and protein levels was associated with favorable prognoses, and ATP7B expression was identified as an independent prognostic factor in multivariate analysis.\"}]","ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer | PDF",1790162716,33,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8daddc08629b6475d1d2f4a36fc6e80.webp",983,1305,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63069adf1f2eb12afc1cd4fc0d27e02b.webp",982,1304,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a45391c6c54520858d8336143b838036.webp",981,1303,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bef43755e79210438ec5e2cc5c99408d.webp",980,1301]